Diazabicyclo[3.3.1]nonane derivatives that inhibit the peptidyl-prolyl isomerase enzyme activity associated with FK-506 binding proteins (FKBP) are described for treating neurological disorders. Also described are compounds useful for preparing such inhibitors.
SULFAMIDE, SULFAMATE, SULFONAMIDE, UREA, AMIDE, ALPHA, ALPHA-DIFLUORO AMIDE OXALYL DIAMIDE, AND HETEROBICYCLES FKBP-BINDING LIGANDS